Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia (Experimental Hematology and Oncology, 2023)

(untitled) - Schneider, P; Crump, NT; Arentsen-Peters, STCJM; Smith, AL; Hagelaar, R; Adriaanse, FRS; Bos, RS; de Jong, A; Nierkens, S; Koopmans, B; Milne, TA; Pieters, R; et al.